Skip to main content

Table 5 Side effects: logistic regression analyses

From: The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis

Side effect Univariable results Multivariable resultsa
Odds ratio CDMF vs CF 95 % CI p value Odds ratio CDMF vs CF 95 % CI p value
Any side effect 7.11 3.45, 14.62 <0.001 7.49 3.54, 15.86 <0.001
Abdominal pain 14.16 3.77, 53.27 <0.001 15.79 4.20, 59.41 <0.001
Flushing 12.92 6.12, 27.25 <0.001 12.51 5.85, 26.76 <0.001
Nausea 3.28 1.45, 7.40 0.004 3.16 1.38, 7.24 0.007
Flu-like symptoms 3.22 0.81, 12.84 0.097 3.02 0.77, 11.82 0.112
Diarrhea 2.22 1.03, 4.77 0.041 2.30 1.06, 5.00 0.035
Cough 1.33 0.51, 3.48 0.563 1.32 0.50, 3.44 0.574
Vomiting 1.24 0.40, 3.89 0.712 1.26 0.41, 3.91 0.683
Back pain 1.00 0.34, 2.91 0.995 0.94 0.33, 2.72 0.915
Headache 0.85 0.43, 1.67 0.635 0.87 0.43, 1.73 0.687
  1. aCovariates: age (continuous), gender (male/female), and Total MSRS-R score (continuous)